New York, NY, United States of America

Charles Peter Althoff

USPTO Granted Patents = 57 

 

Average Co-Inventor Count = 6.4

ph-index = 13

Forward Citations = 446(Granted Patents)

Forward Citations (Not Self Cited) = 407(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Cleveland Heights, OH (US) (2006 - 2010)
  • Cleveland Hts., OH (US) (2008 - 2010)
  • New York, NY (US) (2015 - 2022)
  • Piermont, NY (US) (2020 - 2023)
  • Brooklyn, NY (US) (2012 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
57 patents (USPTO):

Title: The Innovative Journey of Charles Peter Althoff

Introduction: Charles Peter Althoff, a distinguished inventor hailing from New York, NY, has made significant contributions to the world of technology and innovation.

Latest Patents: Charles Peter Althoff holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent focuses on a groundbreaking method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Charles Peter Althoff has worked with renowned tech companies, leading research institutions, and innovative startups. His expertise in developing cutting-edge solutions has earned him a reputation as a visionary in the industry.

Collaborations: Throughout his career, Charles Peter Althoff has collaborated with top engineers, scientists, and designers to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking technologies.

Conclusion: Charles Peter Althoff's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that have a lasting impact on society. His dedication to pushing the boundaries of technology makes him a true pioneer in the field of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…